Urotronic Inc. Clinical Trial Pipeline: 6 Active Trials, 3 Changes This Month

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 1 with a notable change, 0 with minor changes only.

Stopped: an ongoing trial was terminated, suspended or withdrawn.
Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
Minor: routine progress and housekeeping, such as sites added or enrollment closed.

Phase 4

1

Not charted: 5 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

NCT ID	Title	Condition	Status	Updated
Phase 4
NCT05383274	Optilume PoST AppRoval Clinical Evaluation of Andrology ParaMeters	Urethral Stricture	Active, Not Recruiting	2026-09-21
Not applicable
NCT06312722	Safety and Effectiveness of the Optilume® BPH Catheter System in a Post-Market Study	Benign Prostatic Hyperplasia	Recruiting	2026-07-10
NCT07020520	EvaluatioN of Optilume Drug-Coated Balloon for the Endoscopic Treatment of UREteric…	Ureteral Stricture	Recruiting	2026-03-09
NCT04131907	Optilume™ BPH Catheter System in Men With Symptomatic BPH	Benign Prostatic Hyperplasia	Active, Not Recruiting	2026-07-30
NCT03499964	ROBUST III- Re-Establishing Flow Via Drug Coated Balloon For The Treatment Of Urethral…	Urethral Stricture	Active, Not Recruiting	2026-05-19
Not specified
NCT06560476	OPtilume™ BPH Catheter SystEm for Treatment of Men eXperiencing Symptomatic BPH	Benign Prostatic Hyperplasia	Active, Not Recruiting	2026-07-10